Related Experiment Video
Updated: Jun 15, 2026
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Pharmacotherapy of systemic sclerosis
Arnold E Postlethwaite1, L Jeff Harris, Syed H Raza
1Department of Medicine, Division of Connective Tissue Diseases, University of Tennessee Health Science Center, Room G326, Memphis, TN 38163, USA. apostlethwai@uthsc.edu
Expert Opinion on Pharmacotherapy
|March 10, 2010
Summary
Systemic sclerosis (SSc) is a complex autoimmune disease. While no cure exists, targeted therapies can improve quality of life and reduce complications in patients with SSc.
Area of Science:
- Rheumatology
- Immunology
- Vascular Biology
Background:
- Systemic sclerosis (SSc) is a rare autoimmune disorder characterized by fibroproliferation in blood vessels and organs.
- Currently, no definitive cure for SSc is available.
- Understanding SSc pathogenesis is crucial for developing effective treatments.
Purpose of the Study:
- To review current literature on the pathogenesis of Systemic sclerosis (SSc).
- To discuss the treatment of complications associated with SSc.
- To provide insights for physicians managing SSc patients.
Main Methods:
- Comprehensive literature search of the PubMed database for SSc-related research.
- Inclusion of articles on SSc pathogenesis and treatment strategies.
- Review of relevant studies to synthesize current knowledge.
Main Results:
- Exploration of SSc pathogenesis mechanisms, including autoimmunity, vascular changes, and fibrogenesis.
- Review of completed and ongoing clinical trials for organ-specific and global SSc therapies.
- Highlighting current understanding of SSc and its management.
Conclusions:
- SSc is a complex autoimmune disease with ongoing research into its pathogenesis.
- Targeted therapies can improve quality of life and reduce morbidity/mortality in SSc patients.
- Innovative treatment approaches for SSc are under active investigation.
Related Concept Videos
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...